Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000536784 | SCV000656004 | likely benign | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001662603 | SCV001873666 | uncertain significance | not provided | 2021-06-28 | criteria provided, single submitter | clinical testing | In silico analysis supports a deleterious effect on splicing; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 27535533) |
Center for Genomics, |
RCV000536784 | SCV002495972 | uncertain significance | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | 2022-02-03 | criteria provided, single submitter | clinical testing | SPATA5 NM_145207.2 exon 5 p.Gly299Val (c.896G>T): This variant has not been reported in the literature but is present in 0.5% (230/41448) of African alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/4-122934487-G-T?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:475737). This variant amino acid Valine (Val) is present in several species including multiple mammals and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Prevention |
RCV003945322 | SCV004764442 | likely benign | AFG2A-related disorder | 2020-09-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |